|
LRRC70 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.015470E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.059800E-03 |
| Normal-vs-Stage2 |
4.923600E-01 |
| Normal-vs-Stage3 |
1.89775999999142E-05 |
| Normal-vs-Stage4 |
1.44639999977159E-08 |
| Stage1-vs-Stage2 |
1.757770E-01 |
| Stage1-vs-Stage3 |
2.585800E-02 |
| Stage1-vs-Stage4 |
8.31990000000893E-05 |
| Stage2-vs-Stage3 |
5.100100E-03 |
| Stage2-vs-Stage4 |
4.41359999999724E-05 |
| Stage3-vs-Stage4 |
1.028840E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.30129999999606E-05 |
| Normal-vs-AfricanAmerican |
6.854200E-02 |
| Normal-vs-Asian |
6.592600E-04 |
| Caucasian-vs-AfricanAmerican |
8.868000E-01 |
| Caucasian-vs-Asian |
8.468800E-01 |
| AfricanAmerican-vs-Asian |
8.270000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.371400E-04 |
| Normal-vs-Female |
1.959660E-04 |
| Male-vs-Female |
8.578800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.698100E-02 |
| Normal-vs-Age(41-60Yrs) |
6.0846999999975E-05 |
| Normal-vs-Age(61-80Yrs) |
7.6648000000068E-05 |
| Normal-vs-Age(81-100Yrs) |
1.208450E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.213900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.467800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.173400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.303400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.046600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.705400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.29029999965213E-07 |
| Classical-VS-Follicular |
1.66770000031846E-07 |
| Classical-VS-Other |
6.269200E-01 |
| Classical-VS-Normal |
1.51668999999188E-05 |
| Tall-VS-Follicular |
1.64246394263046E-12 |
| Tall-VS-Other |
2.089200E-01 |
| Tall-VS-Normal |
2.1618262735501E-12 |
| Follicular-VS-Other |
4.295600E-02 |
| Follicular-VS-Normal |
1.719600E-01 |
| Other-VS-Normal |
1.717660E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.637640E-02 |
| Normal-vs-N1 |
4.188800E-04 |
| N0-vs-N1 |
3.102000E-02 |
|
|
